Biological E partners with Bavarian Nordic for Chikungunya vaccine in low- and middle-income nations
Biological E partners with Bavarian Nordic to expand access to Chikungunya Vaccine in low- and middle-income countries.
Vaccine Technologies Market Size Predicted To Hit USD 90.6 Billion By 2033 At 6.4% CAGR, Says AMR
Vaccine Technologies Market 2025 market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare ...
Do you know which vaccines you got as a child? Here’s how to track them.
Start with your health-care provider, parents or caregiver to find out about your childhood vaccinations. And learn which ...
Vaccine makers can add clinical trial sites through Sugam, says CDSCO
The recent notice brings applications for biological products such as vaccines and recombinant deoxyribonucleic acid ...
Vietnam Investment Review on MSN9d
AIM Vaccine's mRNA Shingles Vaccine Submits Clinical Application to the U.S.
As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in China is in full swing. On February 23, PRC vaccine leader AIM Vaccine ...
HealthDay on MSN10d
Lost Your Vaccine Records? Here’s How to Track Them Down
With measles cases on the rise and flu season straining the nation's hospitals, health experts urge adults to check th ...
Asian News International on MSN9d
Biological E Limited partners with Bavarian Nordic to increase global access to Chikungunya Vaccine
Hyderabad (Telangana) [India], February 25 (ANI): Biological E Limited (BE) on Tuesday announced a strategic partnership with ...
Deccan Chronicle9d
Biological E Partners With Bavarian Nordic To Increase Access To Chikungunya Vaccine
This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya ...
Medical Dialogues8d
Govt Panel Directs Serum Institute of India to Add Guillain-Barre Syndrome Warning as Rare Side Effect of Covishield Vaccine
The ChAdOx1 viral vector was developed at the University of Oxford and has been investigated as a potential vector for ...
Egg-based flu vaccine production secure despite avian influenza
CLEVELAND, Ohio — Eggs are disappearing from store shelves due to shortages caused by the avian flu outbreak, but never fear — the eggs used to make the flu vaccine are safe.
Hosted on MSN12d
Global influenza vaccine market to hit $14b by 2032
Developments include cell-based and recombinant DNA technologies. The global influenza vaccine market is projected to cross ...